CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

KAZUKI SONE; TETSUYA OGURI; MAKOTO NAKAO; YUSUKE KAGAWA; RYOTA KUROWAKA; HIROMI FURUTA; SATOSHI FUKUDA; TAKEHIRO UEMURA; OSAMU TAKAKUWA; YOSHIHIRO KANEMITSU; HIROTSUGU OHKUBO; MASAYA TAKEMURA; KEN MAENO; YUTAKA ITO; HIDEFUMI SATO; HIDEKI MURAMATSU; AKIO NIIMI

Research ArticleClinical Studies

CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

KAZUKI SONE, TETSUYA OGURI, MAKOTO NAKAO, YUSUKE KAGAWA, RYOTA KUROWAKA, HIROMI FURUTA, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, YOSHIHIRO KANEMITSU, HIROTSUGU OHKUBO, MASAYA TAKEMURA, KEN MAENO, YUTAKA ITO, HIDEFUMI SATO, HIDEKI MURAMATSU and AKIO NIIMI

Anticancer Research February 2017, 37 (2) 935-939;

KAZUKI SONE

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TETSUYA OGURI

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: t-oguri{at}med.nagoya-cu.ac.jp

MAKOTO NAKAO

2Department of Respiratory Medicine, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUSUKE KAGAWA

2Department of Respiratory Medicine, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

RYOTA KUROWAKA

2Department of Respiratory Medicine, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROMI FURUTA

3Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SATOSHI FUKUDA

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKEHIRO UEMURA

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

OSAMU TAKAKUWA

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YOSHIHIRO KANEMITSU

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIROTSUGU OHKUBO

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MASAYA TAKEMURA

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KEN MAENO

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUTAKA ITO

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIDEFUMI SATO

2Department of Respiratory Medicine, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HIDEKI MURAMATSU

2Department of Respiratory Medicine, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

AKIO NIIMI

1Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 37 no. 2 935-939

PMID

28179355

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received December 18, 2016
Revision received January 26, 2017
Accepted January 27, 2017
Published online February 8, 2017.

Author Information

KAZUKI SONE¹,
TETSUYA OGURI¹ ⇑,
MAKOTO NAKAO²,
YUSUKE KAGAWA²,
RYOTA KUROWAKA²,
HIROMI FURUTA³,
SATOSHI FUKUDA¹,
TAKEHIRO UEMURA¹,
OSAMU TAKAKUWA¹,
YOSHIHIRO KANEMITSU¹,
HIROTSUGU OHKUBO¹,
MASAYA TAKEMURA¹,
KEN MAENO¹,
YUTAKA ITO¹,
HIDEFUMI SATO²,
HIDEKI MURAMATSU² and
AKIO NIIMI¹

¹Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
²Department of Respiratory Medicine, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, Japan
³Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

Correspondence to: Tetsuya Oguri, Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan. E-mail: t-oguri{at}med.nagoya-cu.ac.jp

View Full Text

Statistics from Altmetric.com

Cited By...

22 Citations
Citations
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext

In this issue

Anticancer Research

Vol. 37, Issue 2

February 2017

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 5 + 3 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

Anticancer Research Feb 2017, 37 (2) 935-939;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

Anticancer Research Feb 2017, 37 (2) 935-939;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Serum CYFRA 21-1 Level as a Prognostic Marker for Extensive Disease Small Cell Lung Cancer
Variants of SLC22A16 Predict the Efficacy of Platinum Combination Chemotherapy in Advanced Non-small-cell Lung Cancer
TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
Predictive and Prognostic Value of CYFRA 21-1 for Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients

Google Scholar

Keywords

cytokeratin 19 fragment
tumor marker
pemetrexed
non-squamous non-small cell lung cancer

Main menu

User menu

Search

CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords